• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫乳酸脱氢酶的酶学性质

Enzymatic properties of the lactate dehydrogenase enzyme from Plasmodium falciparum.

作者信息

Shoemark Deborah K, Cliff Matthew J, Sessions Richard B, Clarke Anthony R

机构信息

Department of Biochemistry, School of Medical Sciences, University of Bristol, University Walk, Clifton, Bristol, UK.

出版信息

FEBS J. 2007 Jun;274(11):2738-48. doi: 10.1111/j.1742-4658.2007.05808.x. Epub 2007 Apr 25.

DOI:10.1111/j.1742-4658.2007.05808.x
PMID:17459101
Abstract

The lactate dehydrogenase enzyme from Plasmodium falciparum (PfLDH) is a target for antimalarial compounds owing to structural and functional differences from the human isozymes. The plasmodial enzyme possesses a five-residue insertion in the substrate-specificity loop and exhibits less marked substrate inhibition than its mammalian counterparts. Here we provide a comprehensive kinetic analysis of the enzyme by steady-state and transient kinetic methods. The mechanism deduced by product inhibition studies proves that PfLDH shares a common mechanism with the human LDHs, that of an ordered sequential bireactant system with coenzyme binding first. Transient kinetic analysis reveals that the major rate-limiting step is the closure of the substrate-specificity loop prior to hydride transfer, in line with other LDHs. The five-residue insertion in this loop markedly increases substrate specificity compared with the human muscle and heart isoforms.

摘要

恶性疟原虫的乳酸脱氢酶(PfLDH)因其与人类同工酶在结构和功能上存在差异,而成为抗疟化合物的作用靶点。疟原虫酶在底物特异性环中有一个五残基插入,并且与其哺乳动物对应物相比,表现出不太明显的底物抑制作用。在这里,我们通过稳态和瞬态动力学方法对该酶进行了全面的动力学分析。产物抑制研究推导的机制证明,PfLDH与人类LDH具有共同的机制,即辅酶先结合的有序顺序双反应物系统。瞬态动力学分析表明,主要的限速步骤是在氢化物转移之前底物特异性环的闭合,这与其他LDH一致。与人类肌肉和心脏同工型相比,该环中的五残基插入显著提高了底物特异性。

相似文献

1
Enzymatic properties of the lactate dehydrogenase enzyme from Plasmodium falciparum.恶性疟原虫乳酸脱氢酶的酶学性质
FEBS J. 2007 Jun;274(11):2738-48. doi: 10.1111/j.1742-4658.2007.05808.x. Epub 2007 Apr 25.
2
Design, synthesis, and biological evaluation of Plasmodium falciparum lactate dehydrogenase inhibitors.恶性疟原虫乳酸脱氢酶抑制剂的设计、合成及生物学评价
J Med Chem. 2007 Aug 9;50(16):3841-50. doi: 10.1021/jm070336k. Epub 2007 Jul 18.
3
Structure and function of Plasmodium falciparum malate dehydrogenase: role of critical amino acids in co-substrate binding pocket.恶性疟原虫苹果酸脱氢酶的结构与功能:关键氨基酸在辅酶结合口袋中的作用。
Biochimie. 2009 Nov-Dec;91(11-12):1509-17. doi: 10.1016/j.biochi.2009.09.005. Epub 2009 Sep 20.
4
Structure of Toxoplasma gondii LDH1: active-site differences from human lactate dehydrogenases and the structural basis for efficient APAD+ use.刚地弓形虫乳酸脱氢酶1(TgLDH1)的结构:与人类乳酸脱氢酶的活性位点差异及高效利用APAD⁺的结构基础
Biochemistry. 2004 Feb 3;43(4):879-89. doi: 10.1021/bi035108g.
5
Generation of oxamic acid libraries: antimalarials and inhibitors of Plasmodium falciparum lactate dehydrogenase.草氨酸文库的生成:抗疟药及恶性疟原虫乳酸脱氢酶抑制剂
J Comb Chem. 2007 Mar-Apr;9(2):292-300. doi: 10.1021/cc060110n. Epub 2007 Feb 23.
6
Plasmodium falciparum: enhanced soluble expression, purification and biochemical characterization of lactate dehydrogenase.恶性疟原虫:乳酸脱氢酶的增强可溶性表达、纯化及生化特性分析
Exp Parasitol. 2008 Oct;120(2):135-41. doi: 10.1016/j.exppara.2008.06.006. Epub 2008 Jun 21.
7
Plasmodium and host lactate dehydrogenase molecular function and biological pathways: implication for antimalarial drug discovery.疟原虫与宿主乳酸脱氢酶的分子功能及生物学途径:对抗疟药物研发的启示
Chem Biol Drug Des. 2007 Apr;69(4):280-3. doi: 10.1111/j.1747-0285.2007.00495.x.
8
Production and characterization of monoclonal antibodies against substrate specific loop region of Plasmodium falciparum lactate dehydrogenase.针对恶性疟原虫乳酸脱氢酶底物特异性环区的单克隆抗体的制备与特性分析
Immunol Invest. 2014;43(6):556-71. doi: 10.3109/08820139.2014.892962. Epub 2014 Apr 4.
9
Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum.恶性疟原虫乳酸脱氢酶的底物、辅因子特异性及选择性抑制作用
Mol Biochem Parasitol. 1997 Dec 1;90(1):235-46. doi: 10.1016/s0166-6851(97)00140-0.
10
Mapping the binding site for gossypol-like inhibitors of Plasmodium falciparum lactate dehydrogenase.绘制恶性疟原虫乳酸脱氢酶的棉酚样抑制剂的结合位点图谱。
Mol Biochem Parasitol. 2005 Aug;142(2):137-48. doi: 10.1016/j.molbiopara.2005.03.015. Epub 2005 Apr 18.

引用本文的文献

1
Expression, Purification and Biochemical Characterisation of Babesia bigemina Lactate Dehydrogenase.双芽巴贝斯虫乳酸脱氢酶的表达、纯化及生化特性分析
Mol Biotechnol. 2025 Sep 10. doi: 10.1007/s12033-025-01500-x.
2
Penicillium-Derived Inhibitors of Lactate Dehydrogenase (PfLDH): A Computational Approach for Novel Antimalarial Therapy Development.青霉来源的乳酸脱氢酶抑制剂(PfLDH):新型抗疟治疗药物研发的计算方法
Scientifica (Cairo). 2025 Aug 4;2025:8838031. doi: 10.1155/sci5/8838031. eCollection 2025.
3
Nontargeted Metabolomics of Sourced from Thailand Reveals the Presence of Bioactive Metabolites.
源自泰国的[具体来源未给出,原文缺失关键信息]的非靶向代谢组学揭示了生物活性代谢物的存在。
ACS Omega. 2025 Mar 11;10(11):11567-11579. doi: 10.1021/acsomega.5c00669. eCollection 2025 Mar 25.
4
Accelerating Antimalarial Drug Discovery with a New High-Throughput Screen for Fast-Killing Compounds.利用新型高通量筛选快速杀灭化合物加速抗疟药物发现
ACS Infect Dis. 2024 Dec 13;10(12):4115-4126. doi: 10.1021/acsinfecdis.4c00328. Epub 2024 Nov 19.
5
Novel molecular inhibitor design for Plasmodium falciparum Lactate dehydrogenase enzyme using machine learning generated library of diverse compounds.基于机器学习生成的多样化化合物库设计新型疟原虫乳酸脱氢酶分子抑制剂。
Mol Divers. 2024 Aug;28(4):2331-2344. doi: 10.1007/s11030-024-10960-3. Epub 2024 Aug 20.
6
Antimalarial potential of compounds isolated from Mammea siamensis T. Anders. flowers: in vitro and molecular docking studies.从暹罗杨梅的花中分离得到的化合物的抗疟潜力:体外和分子对接研究。
BMC Complement Med Ther. 2022 Oct 12;22(1):266. doi: 10.1186/s12906-022-03742-7.
7
A microfluidic paper analytical device using capture aptamers for the detection of PfLDH in blood matrices.一种基于微流控纸分析装置的捕获适体用于血液基质中 PfLDH 的检测。
Malar J. 2022 Jun 7;21(1):174. doi: 10.1186/s12936-022-04187-6.
8
Purifying and Characterizing Bacterially Expressed Soluble Lactate Dehydrogenase from for the Development of Anti-Malarial Drugs.从 中纯化和鉴定细菌表达的可溶性乳酸脱氢酶,用于开发抗疟药物。
Molecules. 2021 Nov 1;26(21):6625. doi: 10.3390/molecules26216625.
9
Structure, Function, and Thermodynamics of Lactate Dehydrogenases from Humans and the Malaria Parasite .人源和疟原虫乳酸脱氢酶的结构、功能和热力学性质
Biochemistry. 2021 Nov 30;60(47):3582-3595. doi: 10.1021/acs.biochem.1c00470. Epub 2021 Nov 8.
10
Disease variants of human Δ-pyrroline-5-carboxylate reductase 2 (PYCR2).人Δ-吡咯啉-5-羧酸还原酶 2 (PYCR2)的疾病变异体。
Arch Biochem Biophys. 2021 May 30;703:108852. doi: 10.1016/j.abb.2021.108852. Epub 2021 Mar 24.